SBIR-STTR Award

Improving Human Performance through Neuroenhancement
Award last edited on: 3/31/2023

Sponsored Program
SBIR
Awarding Agency
DOD : SOCOM
Total Award Amount
$4,587,768
Award Phase
2
Solicitation Topic Code
SOCOM182-002
Principal Investigator
Daniel Oliver

Company Information

Rejuvenate Bio Inc

235 Freeman Unit 3
Brookline, MA 02116
   (916) 396-3714
   N/A
   www.rejuvenatebio.com
Location: Single
Congr. District: 04
County: Suffolk

Phase I

Contract Number: H9240519P0006
Start Date: 11/9/2018    Completed: 5/9/2019
Phase I year
2018
Phase I Amount
$149,991
Special Operations Forces (SOF) are an integral aspect of the US military. SOF operators are among the most elite and highly qualified individuals in the U.S. military. As such, extraordinary physical and mental demands are placed upon them to excel in extreme environments for extended periods of time. This unrelenting cycle of combat deployments and intense pre-deployment training shortens the functional life of operators, a highly undesirable outcome. Rejuvenate Bio developed a gene therapy platform that identified genes that can increase the stress-resistance, health-span, and lifespan. We believe that these novel gene therapies will also enhance cognitive performance due to the neurotropic and brain specific genes being modulated. As a first step toward developing therapies for humans, we propose to measure the effect of these gene therapies on learning, memory, and focus.

Phase II

Contract Number: H9240520C0004
Start Date: 12/11/2019    Completed: 5/10/2022
Phase II year
2020
(last award dollars: 2022)
Phase II Amount
$4,437,777

Special OperationsForces (SOF)are an integral aspect of the US military. SOF operators are among the most elite and highly qualified individuals in the U.S.military. As such, extraordinary physical and mental demands are placed upon them to excel in extreme environments for extended periods of time. This unrelenting cycle of combat deployments and intense pre-deployment training shortens the functional life of operators, a highly undesirable outcome. Rejuvenate Bio developed a gene therapy platform that identified genes that can increase the stress-resistance, health-span, and lifespan.We believe that these novel gene therapies will also enhance cognitive performance due to the neurotropic and brain specific genes being modulated. As a first step toward developing therapies for humans, we propose to measure the effect of these gene therapies on learning, memory, and focus.